Related Experiment Video
Updated: Jul 30, 2026
12:24
Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers
Published on: July 17, 2012
Gallium-67 localization in rat and mouse tumors
Science (New York, N.Y.)
|January 16, 1970
Summary
Gallium-67 uptake was observed in various non-osseous tumors in rodents. A novel rat neoplasm demonstrated the highest affinity for gallium-67, with uptake localized in viable tumor cell cytoplasm.
Area of Science:
- Oncology
- Nuclear Medicine
- Radiochemistry
Background:
- Gallium-67 (Ga-67) is a radiopharmaceutical used in diagnostic imaging.
- Tumor-specific uptake of radiotracers is crucial for effective cancer detection and characterization.
Purpose of the Study:
- To investigate the concentration of gallium-67 in various non-osseous rodent tumors.
- To identify which tumor types exhibit significant gallium-67 uptake.
- To characterize the cellular localization of gallium-67 within tumor tissues.
Main Methods:
- Administration of gallium-67 to mice and rats bearing different non-osseous tumors.
- Assessment of gallium-67 concentration in tumor tissues.
- Autoradiographic studies to determine cellular and subcellular localization of gallium-67.
Main Results:
- Several non-osseous tumors, including preputial gland carcinoma and lymphosarcoma, concentrated gallium-67.
- A newly developed transplantable rat neoplasm exhibited the highest affinity for gallium-67.
- Autoradiography revealed that viable tumor cells are primarily responsible for gallium-67 uptake, with localization mainly in the cytoplasm.
Conclusions:
- Non-osseous tumors can effectively concentrate gallium-67.
- The novel rat neoplasm shows promise as a model for studying gallium-67 uptake.
- Understanding gallium-67's cellular localization in viable tumor cytoplasm aids in interpreting imaging findings.
